Roche Partners With GE to Develop Integrated Digital Diagnostics Platform
08 January 2018 - 6:17PM
Dow Jones News
By Sonia Amaral Rohter
Roche Holding AG (ROG.EB) said Monday that it has entered into a
strategic partnership with GE Healthcare to jointly develop and
market a digital clinical-decision support platform.
The initial focus of the partnership will be products that
improve individualized treatment options for cancer and
critical-care patients, Roche said.
The two companies will develop jointly-branded clinical-decision
support software, Roche said. The partnership will apply analytics
to data from GE's medical imaging and monitoring equipment with
data from Roche's biomarker, tissue pathology, genomics and
sequencing portfolio.
"We believe this alliance will help accelerate the delivery of
data-driven precision health for customers, patients and the
healthcare industry," said Kieran Murphy, president and chief
executive officer of GE Healthcare.
Write to Sonia Amaral Rohter at
sonia.amaralrohter@dowjones.com
(END) Dow Jones Newswires
January 08, 2018 02:02 ET (07:02 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2024 to May 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From May 2023 to May 2024